Marked Gingival Overgrowth Protruding from the Oral Cavity Due to Sodium Valproate
Drug-induced gingival overgrowth is associated with various systemic diseases, including epilepsy. Among antiepileptic medications, phenytoin is commonly reported to cause this condition. In contrast, sodium valproate (VPA), another widely used antiepileptic drug, rarely induces gingival overgrowth....
Saved in:
| Main Authors: | Mami Uegami, Hiroaki Ito, Tadashi Shiohama |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-01-01
|
| Series: | Diagnostics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-4418/15/2/205 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Calcium Antagonist-Induced Gingival Overgrowth: A Case Report and Literature Review
by: Stefano Speroni, et al.
Published: (2025-01-01) -
Quantification of matrix metalloproteinases MMP-8 and MMP-9 in gingival overgrowth
by: Jennifer Orozco-Páez, et al.
Published: (2021-07-01) -
Cerebroprotective prevention of memory disorders using sodium valproate
by: A. V. Ivanov
Published: (2013-04-01) -
Correlation Between Hyperbaric Oxygen Therapy Course and Reduction of Clonazepam in Patients with Paroxysmal Sympathetic Hyperactivity: A Retrospective Cohort Study
by: LIU Sujuan, et al.
Published: (2024-09-01) -
Clinical characteristics, diagnostic challenges, and outcome of paroxysmal sympathetic hyperactivity in pediatric patients: a retrospective cohort study in a tertiary hospital setting
by: Wesam Althaqafi, et al.
Published: (2025-04-01)